Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0QI9N
|
||||
| Former ID |
DIB010231
|
||||
| Drug Name |
BN-CB-045
|
||||
| Synonyms |
Selective estrogen receptor modulators (female sexual dysfunction); BN-CB-045; BN-ES-022; Selective estrogen receptor modulators (female sexual dysfunction), Bionovo
|
||||
| Indication | Female sexual dysfunction [ICD9: 302.7; ICD10:F52] | Preclinical | [548258] | ||
| Company |
Bionovo Inc
|
||||
| Target and Pathway | |||||
| Target(s) | Estrogen receptor | Target Info | Modulator | [548259] | |
| Pathway Interaction Database | Regulation of nuclear SMAD2/3 signaling | ||||
| Signaling events mediated by HDAC Class II | |||||
| Plasma membrane estrogen receptor signaling | |||||
| LKB1 signaling events | |||||
| Regulation of Telomerase | |||||
| ATF-2 transcription factor network | |||||
| AP-1 transcription factor network | |||||
| FOXM1 transcription factor network | |||||
| Validated nuclear estrogen receptor alpha network | |||||
| Signaling mediated by p38-alpha and p38-beta | |||||
| FOXA1 transcription factor network | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.